Additionally, G‐protein‐coupled receptors (GPCRs), such as cysteinyl leukotriene receptor antagonists, have been found to reduce YAP/TAZ nuclear localization, thereby inhibiting their activity in various cancer cell types [21]. This evidence concerns the gene YAP1 and cancer.